Volume 88, Issue 2 pp. 113-115
Brief Research Communication
Full Access

No association between the genes for butyrylcholinesterase K variant and apolipoprotein E4 in late-onset Alzheimer's disease

Chang-Seok Ki

Chang-Seok Ki

Department of Clinical Pathology, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, South Korea

Search for more papers by this author
Duk Lyul Na

Duk Lyul Na

Department of Neurology, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, South Korea

Search for more papers by this author
Jong-Won Kim

Corresponding Author

Jong-Won Kim

Department of Clinical Pathology, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, South Korea

Department of Clinical Pathology, Samsung Seoul Medical Center, 50 Ilwon-Dong, Kangnam-Gu, Seoul 135-710, South KoreaSearch for more papers by this author
Hye Jin Kim

Hye Jin Kim

Samsung Biomedical Research Institute, Seoul, South Korea

Search for more papers by this author
Doh Kwan Kim

Doh Kwan Kim

Department of Psychiatry, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, South Korea

Search for more papers by this author
Byung-Koo Yoon

Byung-Koo Yoon

Department of Obstetrics and Gynecology, Sungkyunkwan University College of Medicine, Samsung Medical Center, Seoul, South Korea

Search for more papers by this author

Abstract

Butyrylcholinesterase (BChE) as well as acetylcholinesterase has been suggested to be associated with Alzheimer's disease (AD). Lehmann et al. [1997: Hum Mol Genet 6:1933–1936] recently reported the synergism between the gene for the K variant of BChE (BCHE-K) and the ϵ4 allele of apolipoprotein E (APOE ϵ4) in late-onset confirmed AD with Caucasian subjects. The authors found that the allelic frequency of BCHE-K was 0.17 in 74 subjects with late-onset histopathologically diagnosed AD, which was higher than the frequencies in elderly control subjects (0.09) and in other dementias (0.07–0.10). The association of BCHE-K with late-onset AD was limited to carriers of APOE ϵ4, giving odds ratios of confirmed late-onset AD of 6.9–12.8. In the present study, we report the BCHE-K allelic frequencies in late-onset AD cases and in age-matched controls of the Korean population, which were 0.22 and 0.17, respectively. We could not find any association between BCHE-K and AD regardless of APOE ϵ4 carrier status. However, APOE ϵ4 clearly showed higher frequency in AD (0.33) than in elderly controls (0.09), giving an odds ratio of 5.2 (95% confidence interval, 2.7–10.0). Our results do not support the conclusion that BCHE-K, or a nearby gene on chromosome 3, acts in synergy with APOE ϵ4 as a susceptibility gene for late-onset AD, at least in the Korean population. Am. J. Med. Genet. (Neuropsychiatr. Genet.) 88:113–115, 1999. © 1999 Wiley-Liss, Inc.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.